NHS England restarted Specialized High-Cost Tariff-Excluded Devices (HCTED) program

06

Oct 2020

A new nationwide system for specific categories of high-cost tariff-excluded devices (HCTED) was introduced in April 2016. The objective is to centralize purchase and supply within the new NHS Supply Chain Operating Model, so deliver better quality and realize value for medical devices. Device Working Groups (DWGs) were established to optimize device choice across the identified categories and perform horizon scanning to accelerate the adoption of new devices. NHS England Specialised Commissioning and NHS Supply Chain are working with NHS Providers to support the transformation to this new framework.

NHS England announced that the HCTED program is restarted working from July - August 2020, following the COVID-19 outbreak. The following areas considered to be back to work first:

  • New migrations to the central supply route, because this area of work can bring more value while other cost-cutting initiatives may be more difficult to implement at this challenging time
  • Clinical optimization of HCTEDs - device working groups (DWG) will be re-engaged with the practical clinical chairs and advisors after a pause in their involvement during the recent months
  • The Financial Reconciliation Process (FRP) will be re-introduced on October 01, 2020. Clear guidance on the requirements of this process is planned to be shared before it.

See more information here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

21

Mar 2022

The NHS Insights Prioritisation Programme (NIPP) is commissioned by the NHS Accelerated Access Collaborative (AAC) and the National Institute for Health Research (NIHR). It is designed to accelerate the evaluation and implementation of innovation that supports post-pandemic ways of working, builds service resilience, and delivers benefits to patients. Fourteen projects have been funded and have now commenced activity that will be ongoing until March 2023.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more